Pasithea Therapeutics (KTTA) Operating Leases (2022 - 2024)

Pasithea Therapeutics recorded quarterly Operating Leases of $32989.0 in Q1 2024, down 59.61% quarter-over-quarter from $81680.0 in Q4 2023, and down 92.91% year-over-year from $465454.0 in Q2 2023.

Pasithea Therapeutics' Operating Leases history runs 3 years deep, the most recent figure standing at $32989.0 for Q1 2024.

  • In Q1 2024, Operating Leases fell 92.91% year-over-year to $32989.0; the TTM figure through Mar 2024 stood at $32989.0 (down 92.91% YoY), while the FY2023 annual figure was $81680.0, down 76.26% from the prior year.
  • Operating Leases came in at $32989.0 for Q1 2024 at Pasithea Therapeutics, down from $81680.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $724386.0 in Q3 2022 to a low of $32989.0 in Q1 2024.
  • A 3-year average of $352227.9 and a median of $371766.5 in 2022 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases grew 18.85% in 2023 and tumbled 92.91% in 2024, its largest moves.
  • Pasithea Therapeutics' Operating Leases stood at $344021.0 in 2022, then plunged by 76.26% to $81680.0 in 2023, then tumbled by 59.61% to $32989.0 in 2024.
  • According to Business Quant data, Operating Leases over the past three periods registered $32989.0, $81680.0, and $385288.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Pasithea Therapeutics 17.41 Mn 17.41 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 32,989.00
Dec 31, 2023 81,680.00
Sep 30, 2023 385,288.00
Jun 30, 2023 256,084.00
Mar 31, 2023 465,454.00
Dec 31, 2022 344,021.00
Sep 30, 2022 724,386.00
Jun 30, 2022 358,245.00